Showing results (171-180 of 317) with videos related to
Sort By:
Pageof 32
European Journal of Internal Medicine|March 14, 2016
Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort studyJ Perez Botero, W D Ormsby, A A Ashrani, et al.Leukemia & Lymphoma|July 13, 2019
QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropeniaJason N Barreto, Michael W Cullen, Kristin C Mara, et al.Human Pathology|December 7, 2025
Gene expression signatures of shortened-telomere-associated fibrotic interstitial lung diseaseJulia R Naso, Carlos Sosa, Lauren E Schefter, et al.Clinical Cardiology|June 30, 2000
The prediction of coronary atherosclerosis employing artificial neural networksJ George, A Ahmed, M Patnaik, et al.Proceedings of the National Academy of Sciences of the United States of America|January 3, 2025
A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemiaZhen Dong, Hugo Sepulveda, Leo J Arteaga-Vazquez, et al.Blood Cancer Journal|January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2016
Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic DosingMoussab Damlaj, Hassan B Alkhateeb, Mehrdad Hefazi, et al.Annals of Hematology|January 25, 2020
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring systemOmar Alkharabsheh, Mrinal M Patnaik, Naseema Gangat, et al.Leukemia & Lymphoma|October 1, 2016
Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromesPrashant Sharma, Shivani S Shinde, Moussab Damlaj, et al.American Journal of Hematology|September 26, 2018
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelideAyalew Tefferi, Natasha Szuber, Rangit R Vallapureddy, et al.Pageof 32